FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/09/2024
Back to search
Official data from USPTO
NEXPOWDER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
11/09/2024
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
03/18/2020
Registration date
04/23/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/23/2024
Last transaction
04/23/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
KR
Examiner
HARMON, RAYMOND E
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a cyan radial design on the left, in the shape of a large hollow circle formed by small shaded circles arranged in rows of decreasingly smaller circles from the perimeter outward. To the right of the design is the cyan stylized wording, "NEXPOWER".
Holders and representatives
Holders
NEXTBIOMEDICAL CO., LTD.
Representatives
KISUK LEE HARNESS, DICKEY & PIERCE, PLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicines for the treatment of gastrointestinal ulcer for animals; anti-adhesion gels for use with wound drainage devices for gastrointestinal endoscopic use; pharmaceutical preparations for wounds; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations for the treatment of cancer; gelatin for medical purposes, namely, pharmaceutical gels for use in controlling bleeding for gastrointestinal endoscopic use; hemostatics for medical purposes for gastrointestinal endoscopic use; chemical preparations for medical purposes for gastrointestinal endoscopic use, namely, for treating gastrointestinal bleeding; pharmaceutical compositions in the nature of endoscopic hemostatic agents for gastrointestinal endoscopic use; pharmaceuticals for the treatment of gastrointestinal ulcer; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the treatment of tumors; haemostatic preparations for medical purposes for gastrointestinal endoscopic use; anti-cancer preparations; vasoconstrictors; surgical cements in the nature of bone cement for surgical and orthopedic purposes; surgical glues; medical adhesives for binding wounds
Publications
History of USPTO decisions and trademark events.
46 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/22/2024
FIMP
FINAL DISPOSITION PROCESSED
10/22/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/24/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/23/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
04/23/2024
TMBN
TTAB RELEASE CASE TO TRADEMARKS
03/15/2024
OP.T
OPPOSITION TERMINATED NO. 999999
03/15/2024
OP.D
OP.DS (DISMISSED IN PART/SUSTAINED IN PART)
12/15/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
10/10/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/22/2021
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
09/22/2021
RFNT
REFUSAL PROCESSED BY IB
04/12/2021
OP.I
OPPOSITION INSTITUTED NO. 999999
03/15/2021
GPNX
NOTIFICATION PROCESSED BY IB
03/14/2021
OPNS
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
03/12/2021
OPNC
OPPOSITION NOTICE (IB REFUSAL) CREATED
03/12/2021
OPPF
OPPOSITION PAPERS RECEIVED AT TTAB
03/11/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/09/2021
PUBO
PUBLISHED FOR OPPOSITION
03/09/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/24/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/24/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/17/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/01/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
02/01/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/01/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
02/01/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/01/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/30/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/30/2021
ALIE
ASSIGNED TO LIE
01/29/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/21/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/21/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/21/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/21/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/21/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/21/2020
RFNT
REFUSAL PROCESSED BY IB
08/14/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/29/2020
RFRR
REFUSAL PROCESSED BY MPU
07/29/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/17/2020
CNRT
NON-FINAL ACTION WRITTEN
06/16/2020
DOCK
ASSIGNED TO EXAMINER
06/09/2020
MAFR
APPLICATION FILING RECEIPT MAILED
04/24/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/20/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/16/2020
Continuous trademark protection
Get notified about every new filing that threatens NEXPOWDER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.